首页 / 产品 / 蛋白 / 细胞因子、趋化因子与生长因子
| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | FGF4 |
| Uniprot No | P08620 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 31-206aa |
| 氨基酸序列 | MAPTAPNGTL EAELERRWES LVALSLARLP VAAQPKEAAV QSGAGDYLLG IKRLRRLYCN VGIGFHLQAL PDGRIGGAHA DTRDSLLELS PVERGVVSIF GVASRFFVAM SSKGKLYGSP FFTDECTFKE ILLPNNYNAY ESYKYPGMFI ALSKNGKTKK GNRVSPTMKV THFLPRL |
| 预测分子量 | 22 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于FGF4重组蛋白的3篇参考文献概览：
---
1. **文献名称**：*"Expression and functional characterization of recombinant human FGF4 in mammalian cells"*
**作者**：Li Y. et al.
**摘要**：研究报道了在哺乳动物细胞(HEK293)中高效表达重组人FGF4蛋白的方法，验证其通过激活MAPK信号通路促进成纤维细胞增殖的生物学活性，为后续药物开发提供基础。
2. **文献名称**：*"Purification and characterization of FGF4 recombinant protein for cartilage regeneration"*
**作者**：Smith J.R., Lee T.K.
**摘要**：通过大肠杆菌表达系统纯化FGF4重组蛋白，并证明其在体外可显著增强软骨细胞分化和细胞外基质合成，提示其在骨关节修复中的潜在应用价值。
3. **文献名称**：*"FGF4 recombinant protein enhances induced pluripotent stem cell reprogramming efficiency"*
**作者**：Wang H. et al.
**摘要**：研究发现FGF4重组蛋白可通过调控Oct4和Sox2等关键基因表达，显著提高iPSC重编程效率，为干细胞治疗技术优化提供了新策略。
---
以上文献涵盖FGF4重组蛋白的表达、功能验证及在再生医学中的应用，均为领域内代表性研究。
Fibroblast Growth Factor 4 (FGF4) is a member of the FGF family, a group of signaling proteins critical in embryonic development, tissue repair, and metabolic processes. Discovered in the 1980s, FGF4 plays a pivotal role in regulating cell proliferation, differentiation, and survival by binding to fibroblast growth factor receptors (FGFRs) and activating downstream signaling pathways, including MAPK and PI3K-AKT. Its expression is tightly controlled during embryogenesis, particularly in limb development, neural tube formation, and organogenesis. Dysregulation of FGF4 has been linked to developmental disorders and cancers, underscoring its biological significance.
Recombinant FGF4 protein is produced using genetic engineering techniques, typically expressed in *E. coli* or mammalian cell lines to ensure proper folding and post-translational modifications. This engineered protein retains the biological activity of native FGF4. enabling its use in research and therapeutic applications. In regenerative medicine, recombinant FGF4 is explored for its potential to stimulate stem cell proliferation and tissue regeneration. It also serves as a tool to study FGF signaling mechanisms in developmental biology and disease models.
Despite its promise, challenges remain in optimizing delivery methods and minimizing off-target effects. Ongoing research focuses on enhancing stability, bioavailability, and tissue-specific targeting. As a multifunctional growth factor, recombinant FGF4 continues to bridge gaps in understanding developmental pathways and advancing biomedical therapies.
×
